Payment & Shipping Terms:
|CAS:||866460-33-5||Product Name:||2-(2-(1-naphthoyl)-8-fluoro-1,2,3,4-tetrahydropyrido[4,3-b]indol-5-yl)acetic Acid|
|Type:||Pharmaceutical Intermediate||Appearance:||White Powder|
|Usage:||For Anti Hair Loss||Alias:||Setipiprant|
Product name: Setipiprant
CAS NO: 866460-33-5
Grade: Medicine Grade ° C
Setipiprant (INN) is a drug originally developed by Actelion which acts as a selective, orally available antagonist of the prostaglandin D2 receptor 2 (DP2). It was initially researched as a treatment for allergies and inflammatory disorders, particularly asthma, but despite being well tolerated in clinical trials and showing reasonable efficacy against allergen-induced airway responses in asthmatic patients, it failed to show sufficient advantages over existing drugs and was discontinued from further development in this application.
A phase 2A study is underway to evaluate the safety, tolerability, and efficacy of oral setipiprant relative to a placebo and the active comparator, finasteride, in 18 to 41 years old males with androgenetic alopecia.
99% Setipiprant 866460-33-5 Pharmaceutical Raw Materials For Anti Hair Loss
Contact Person: Linda Yang